About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

26

Apr

2017

Express Scripts: Amerigroup - Claims Processing Changes

Effective April 17th 2017 Therapy Duplication DUR soft edits

Amerigroup currently uses passive alerts for DUR therapy duplication edits.

26

Apr

2017

Envolve Pharmacy Solutions : Louisiana Healthcare Connections

Effective May 1, 2017

The Louisiana Department of Health (LDH) has issued a notice stating that in order to comply with the Medicaid Services (CMS) Covered Outpatient Drugs Final Rule (CMS-2345-FC), Fee for Service (FFS) reimbursement on 340B Outpatient Pharmacy claims must be modified.

26

Apr

2017

Prime Therapeutics: Claims Processing Outage Notification

Saturday April 29, 2017 11:00 p.m. to Sunday April 30, 2017 5:00 a.m. (CST)

Due to system maintenance at Prime Therapeutics, our claims processing system will be unavailable for claims adjudication during the time frame listed below.

26

Apr

2017

CVS Caremark : Pharmacy Update - Aetna Better Health of Florida

Reject 70 : << NDC Not Covered >>

Aetna Better Health of Florida is an existing plan sponsor with CVS Caremark®.

26

Apr

2017

Argus : Bulletin - Health Partners Change in Anti-Nausea Drug Processing – Part B vs. Part D Status

BIN: 012353 PCN: 05650000

According to CMS guidance, as described in Chapter 6 of the Drug Benefit Manual, “oral anti-nausea drugs used as part of an anti-cancer chemotherapeutic regimen as a full therapeutic replacement for an intravenous anti-emetic drug within 48 hours of chemotherapy administration” is covered by Health Partners Medicare (HPM) as a Part B drug.

First459461Last